Medicine

Pharmacology Infectious Diseases Neurology Oncology Immunology Vaccines Vaccinology Epidemiology Clinical Trials Nobel Prize Cardiology Neuroscience Research Medical Research Virology Clinical Research Obstetrics Pharmaceuticals Endocrinology Surgery Regenerative Medicine Nobel Prize in Medicine Therapeutics Dermatology Orthopedics Public Health Drug Development Reproductive Health Psychiatry Genetics Medical Technology Transplantation Pediatrics Awards Medical Devices Cancer Pathology Ophthalmology Surgical Techniques Neonatology Regulatory Affairs Medical Ethics Transplants Vaccine Development Genetic Research Immunotherapy Psychopharmacology Immunization Anatomy Nanomedicine Geriatrics Cancer Research Antibiotics Translational Medicine Reproductive Medicine Alternative Medicine Case Reports mRNA Vaccines Biomedical Research Molecular Biology Research Studies Cardiovascular Health Gynecology Transplant Surgery Nutritional Science Pharmacy Therapeutic Interventions MRI Technology Occupational Health Nuclear Medicine Gynaecology Cancer Treatment Vaccine Efficacy Research Methodology Biotechnology Drug Efficacy Blood Transfusion Microbiology Allergy Research Neurosurgery Trauma Surgery Neonatal Care Neonatal Medicine Metabolism Radiology Metabolic Medicine Public Health Research Pulmonology Precision Medicine Modern Medicine Chronic Infection Bioweapons Innovative Treatments Immune System Integrative Medicine Cell Biology Antibiotic Development Medical History Immunosuppressants Genetic Diseases

Biobank Study Finds Many Inherited Blindness Mutations Have Low Penetrance

Population-scale data point to ascertainment bias in clinic-based estimates of Mendelian disease risk.

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

FDA Fast-Tracks Augmentin XR in First Approval Under National Priority Voucher Pilot

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

FDA Rejects Biohaven’s Vyglxia for Spinocerebellar Ataxia

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

Engineered Salmonella Triggers Tumor Immune Hubs, Slows Colorectal Cancer in Mice

Studies Show Lymph Nodes Sustain Stem-Like T Cells That Power Cancer Immunotherapy

Maze Therapeutics Reports Strong Phase 1 Signal for MZE782, Announces $150 Million Private Placement

Early Zebrafish Heartbeats Drive Self-Organizing Cardiac Trabecular Growth

Vertex Halts VX-993 Acute Pain Program After Phase 2 Trial Failure

Mayo Clinic Administers First U.S. Alpha-Emitter Therapy for Metastatic Breast Cancer

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

FDA Flags Possible License Revocation for Sarepta’s Elevidys

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research

Minnesota Boy Makes Full Recovery Months After Arrow Pierced His Brain

Surveys Reveal Men Largely Unaware of Their Osteoporosis Risk